Type I interferon (IFN) is a strong immune activator found in high concentrations in the majority of patients with lupus, an autoimmune disease. In Arthritis & Rheumatology, researchers report positive results from the first placebo-controlled long-term trial of anifrolumab, a human mon
Though the COVID-19 pandemic provided a brief respite, influenza virus is back in circulation and, as usual, poses a special danger to people over the age of 65. But why are older people more susceptible to the flu? New research from the U-M Medical School, published in Nature Communications
Blood stem cell transplantation is a radical but highly effective therapy for multiple sclerosis. A study has now examined in detail the way in which the treatment curbs the autoimmune disease and how the immune system regenerates afterward. A better understanding of these mechanisms should
An experimental therapeutic cancer vaccine induced two distinct and desirable immune system responses that led to significant tumour regression in mice, report investigators.
According to a new study by Weill Cornell Medicine investigators, a typical gut bacterium that can spread through the body and cause a serious infection resists natural immune defences and antibiotics by enhancing its protective outer layer, known as the cell envelope.
Investigators have reported an experimental therapeutic cancer vaccine induced two distinct and desirable immune system responses that led to significant tumor regression in mice.
An innovative technology developed at Tel Aviv University will enable bone regeneration to correct large bone defects by means of a special hydrogel. Following successful tests in an animal model, the researchers now plan to move forward to clinical trials.
Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism can be neutralized.
Pseudomonas aeruginosa (P.a.) are resistant to most antibiotics and cause life-threatening infections of wounds or the lungs. The P.a. bacteria species has an entire arsenal of strategies for evading the immune system and infecting tissue. Researchers working with Prof. Dr. Winfried Romer an